Fig 1.
Map of the state of Rio de Janeiro showing georeferenced PCM cases from this study according to health access and urban-rural distribution.
Table 1.
Demographic, clinical, and prognostic profile in 29 acute juvenile PCM patients.
Table 2.
Serological and therapeutic results in 29 acute juvenile PCM patients.
Table 3.
Clinical specimens from which PCM was diagnosed.
Fig 2.
Lymph node and skin involvement in 2 patients from the present study.
(A) Cervical lymph node enlargement with a “bull’s neck” appearance in a female patient. (B) The same patient after 35 months of amphotericin B, itraconazole, and sulfamethoxazole/trimethoprim treatment. (C) Extensive ulcerative skin lesions on the face of a male patient. (D) The same patient after 48 months of sulfamethoxazole/trimethoprim treatment. Photographs by ACFV were obtained for registration of the patients’ recovery. Both individuals agreed to have their photographs taken and published.
Table 4.
Affected organs in acute juvenile PCM cases from this study.
Fig 3.
Therapeutic regimen prescribed for the treatment of 29 acute juvenile PCM cases from this study.
AMB (amphotericin B) and SMZ/TMP (sulfamethoxazole/trimethoprim). Others: itraconazole + SMZ/TMP; AMB + SMZ/TMP; and AMB + fluconazole + SMZ/TMP.